Guidea

Meet five startups that will provide women with life saving proactive care. What does proactive care entail? Detecting conditions before they become a life threatening problem including postpartum hemorrhage, postpartum depression, preterm birth, and preeclampsia. Learn and more about how femtech is transforming healthcare for all humans by focusing on ✨ Proactive vs reactive care ✨ Empower vs disempowered care ✨ Completely reimagined vs incrementally redesigned solutions Novocuff, Inc., Pregnolia AG, Armor Medical Inc, Dionysus Digital Health, Health Evolve Read our article on Fast Co. to learn more, link in comments.

Dexcom Introduces Generative AI Platform for Glucose Biosensing: The Stelo platform analyzes individual health data patterns to provide personalized insights and recommendations for improving metabolic health. Stelo is designed for adults (18+) who do not use insulin or experience hypoglycemia, including those with prediabetes, type 2 diabetes, or even individuals without diabetes. Will these integrated insights and contextual support features make other Diabetes DTx products superfluous or will there be room for both in the market? Follow Guidea for a full assessment of the product experience as this goes live in the market.

An estimated 6.7 million Americans age 65 and older are living with Alzheimer's dementia today. The NIH shows that home care for the elderly with dementia can help avoid readmissions to hospital, reduce costs, bring benefits to their current and family life, in addition to optimizing their life and health. But caregivers shoulder large amounts of stress in coordinating care and support for their loved ones. We are proud to support Amalgam Rx deliver a solution for these caregivers. The unique AI solution, Elevmi, is run by a state-of-the-art large language model (LLM) trained on content from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), and PsychU, the leading online resource for mental health. Available now on the App Store and Play Store. #digitalhealth #healthinnovation #agetech

Last call for applications for the 2nd Innovation in Women's Health Pitch Competition in San Francisco Jan 13th, the week of JP Morgan Health. Femovate by Guidea is partnering with Aquillius to support one winning medtech & one winning therapeutic startup advance their vision for women's health. Apply by December 1st. It only takes 30-45 minutes to apply: https://lnkd.in/gzxkbGVk

Congratulations to the entire Finix team for the recent $75M raise to take on Stripe 💹 If you want to see Finix in action (and their award winning designs), this video will give you a glimpse at the power and value of the platform: https://lnkd.in/gaVUG9RA #fintech #designinnovation #paymentplatform

We're learning about Healthspan vs Lifespan today at the HITLAB Women's Tech Challenge from the talented and respected Jennifer Garrison of Buck Institute for Research on Aging. Ovarian aging is a key component of this, with ovaries aging faster than the rest of the tissues in the women's body and we need to learn more to improve women's healthspans. Women spend 25% more time in poor health than men. While women generally live six years longer than men, a report from the World Economic Forum and McKinsey Health Institute finds that women will spend an average of nine years in poor health throughout their lifetimes (men average a little over seven years). The important work our incubator, Femovate by Guidea, and HITLAB's Women's Health Challenge will improve women's healthspan. Looking forward to seeing who receives the awards later today. #healthinnovation #healthequity #womenshealth

Please join us on Friday for the 2024 Women's Health Tech Challenge with HITLAB. Our founder, Theresa Neil, will be speaking along with other esteemed panelists and HITLAB Director Stan Kachnowski PHD MPA Anna Zornosa & Sarah Temkin from The National Institutes of Health Jennifer Garrison from Buck Institute for Research on Aging Claret Presley, DNP, MBA, RN, CNOR from Sutter Health Dr. Ainsley MacLean from Kaiser Permanente Ventures Sue Merrigan from Evergreen Nephrology Savitha Srinivasan from Trace3 Michelle Hoy from Vitalic Health Victoria Iezzi, CPA from Withum Kristopher Brown (he/him/his) from Goodwin

We're excited to support Techstars Physical Health Fort Worth Accelerator to provide product design & research expertise to 3 of the 11 startups in this year's cohort. These companies were chosen from thousands of startups worldwide, representing the best and brightest in physical health innovation. Meet the teams: Nerveli Nerveli is a mobile application that provides users with an empathetic and interactive pain recovery assistant by combining proven medical science, gamified Cognitive Behavioral Therapy, and machine learning. Revella Health Revella Health's ARIA platform uses AI to analyze patient-provider conversations in real-time, automating documentation, optimizing risk adjustment, and providing actionable insights to improve care delivery and outcomes for complex patients in Medicare Advantage and FQHC settings. Syndicate Bio Syndicate Bio is accelerating precision medicine, drug discovery, and development by including clinical and genomic datasets from the world’s most diverse regions. A huge thank you to Trey Bowles and Jordan Warnement for their leadership and commitment to better health outcomes! #healthinnovation #medtech #healthtech #digitalhealth #healthequity

We're partnering with HITLAB on the 2024 Women's Health Tech Challenge by providing our Femovate by Guidea sponsorship to the Pre-seed team! 🎉 All 6 finalists will pitch their innovative solutions to a panel of judges virtually on October 11th from 1-5:30 PM ET. 👉 Register for free here: https://lnkd.in/eie5uGKC Congratulations to the finalists: Non-Profit Organizations 🎉 Maisha Meds 🎉 Icahn School of Medicine at Mount Sinai Pre-Seed 🎉 Nawara Health - نوارة لصحة المرأة 🎉 Myri Health (Google '24/Techstars '23) Seed 🎉 Partum Health 🎉 Bone Health Technologies | Osteoboost #WomensHealthcare #FemTech #WomenSupportingWomen #DigitalHealth #Innovation #HealthTech #Competition #PitchDay

Deloitte just shared a study exploring what’s causing US women to skip or delay medical care. The three reasons noted in the study are: 1. Affordability 2. Access 3. Prior Experiences Since diving deep into women's health, we've written extensively about the impact of prior experiences adversely influencing women's health outcomes and the opportunity for service and product design to create a new chapter in women's health. The study notes "When symptoms for a woman don’t match the established data (which is typically based upon men), patients could be misdiagnosed or ignored. Additionally, taking the time to build trust and listen to community voices is important but frequently overlooked. For example, in focus groups conducted in a previous Deloitte US study, more than 40% of female participants said they had skipped or avoided care because they didn’t like the way a provider or a staff member treated them. Some of the women participants said clinicians discounted their symptoms, didn’t listen to their concerns, or misdiagnosed a health issue. Such interactions with health care providers can create negative experiences that could erode trust and lead women to avoid necessary care." We spoke about this in our article for Fast Company on Spite Tracking and the trend among women to use digital health and at-home testing kits to fully document and validate their symptoms and experiences and come armed to appointments with proof of their experiences and suspected diagnoses. And while this may seem like a negative trend, it may be just what women's health needs to further research and innovation in this space. #healthequity #womenshealth #femtech